Fairfax Financial Holdings Limited, through a wholly-owned subsidiary, acquired Pethealth Inc. on November 14, 2014. The acquisition was effected under a statutory plan of arrangement of Pethealth pursuant to which holders of Pethealth common shares received $2.79 in cash per each common share and holders of Pethealth preferred shares received $2.79 in cash per each preferred share plus all accrued and unpaid dividends up to, but excluding, the effective date of the plan of arrangement. The transaction was valued at approximately $100 million.
Fairfax was represented by a team from McCarthy Tétrault LLP that included David Tennant, Ian Michael, Deandra Schubert and Jennifer Organ (M&A); Kate McNeill-Keller (employment); Geoff Hall (litigation) and Gabrielle Richards (tax).
Pethealth was represented by Stikeman Elliott LLP with a team that included Curtis Cusinato, Sean Vanderpol, Mike Devereux, Nick Badeen, Amit Bhanot and Logan Copen (M&A); Nancy Ramalho (employment); Ellen Snow (litigation) and John O'Connor (tax).
The Special Committee of Pethealth was represented by Baker & McKenzie LLP with a team that included Charlie MacCready and Nancy Hamzo.
Fairfax was represented by a team from McCarthy Tétrault LLP that included David Tennant, Ian Michael, Deandra Schubert and Jennifer Organ (M&A); Kate McNeill-Keller (employment); Geoff Hall (litigation) and Gabrielle Richards (tax).
Pethealth was represented by Stikeman Elliott LLP with a team that included Curtis Cusinato, Sean Vanderpol, Mike Devereux, Nick Badeen, Amit Bhanot and Logan Copen (M&A); Nancy Ramalho (employment); Ellen Snow (litigation) and John O'Connor (tax).
The Special Committee of Pethealth was represented by Baker & McKenzie LLP with a team that included Charlie MacCready and Nancy Hamzo.
